AstraZeneca PLC (AZN) Description, Stock price, News & Info.

#ThinkSabio Latest News

ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy